HeartWare vote for US move

By Dylan Bushell-Embling
Wednesday, 17 September, 2008

Medical device company HeartWare [ASX: HTW] has received federal court approval to go ahead with shareholder meetings to vote on its plans to redomicile in the US.

Meetings are planned for October 22.

HeartWare has appointed BDO Kendalls Corporate Finance (QLD) to independently assess the proposed scheme. BDO has determined that the scheme is in the best interest of all stockholders.

Related News

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...

Content from other channels on our network

EPOC Enviro secures patent for PFAS remediation technology

NSW passes legislation to mandate battery recycling

Climate Council rates political parties on climate

Boral secures grant for cement kiln carbon reduction

Vast secures grant to progress SA Solar Fuels project

SafeWork NSW discussions increase security at Grafton Base

Permanent identification to follow proven sexual misconduct

Man charged over alleged antisemitic incident in hospital lift

Medical logistics provider gains on-brand hi-vis workwear

Western Sydney Local Health District prosecution withdrawn

Food industry and goverment repond to US tariff imposition

Getting the right texture: toolkit to help create more appealing food

A message from a sponsor of FoodTech Qld

Matthews' stand offering deep 2D barcoding intel at FoodTech Qld

Aranet supermarket temperature monitoring solution

All content Copyright © 2025 Westwick-Farrow Pty Ltd